Shareprice
08 Nov 2025

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2021

3 February, 2021 FluoGuide plans to change listing venue from Spotlight to Nasdaq First North Sweden and publishes Company Description News Corporate Information Other Corporate Information English IR
FluoGuide has advanced rapidly since its IPO. The change of listing venue is a natural consequence of this. It will also provide optimal...
FluoGuide hereby updates on the status of its published patents and patent applications. Since prior to the IPO, FluoGuide holds the...
26 January, 2021 FluoGuide A/S publishes annual report for the fiscal year 2020 News English Regulatory Listing Regulation Report Annual IR
Fourth quarter 2020 (1 October – 31 December): Full year 2020 (1 January – 31 December): *) Result per share (DKK per share)...
26 January, 2021 FluoGuide A/S publishes Year-end report for 2020 News English Regulatory Listing Regulation Report Interim Yearend IR
Fourth quarter 2020 (1 October – 31 December): Full year 2020 (1 January – 31 December): *) Result per share (DKK per share)...
25 January, 2021 Ordinary General Meeting News Corporate Information General meeting Notice English Regulatory Listing Regulation IR
To the shareholders of FluoGuide A/S The board of directors hereby convenes an ordinary general meeting of FluoGuide to be held on...
25 January, 2021 Change in the Board of Directors of FluoGuide News Corporate Information Staff change English Regulatory MAR IR
Arne Ferstad, the Chairman of the Board of Directors, has notified FluoGuide that he will not stand for re-election at the upcoming...
20 January, 2021 Financial calendar for 2021 News Corporate Information Financial calendar English IR
Financial calendar for 2021: Year-end report 2020 (Q4): 26 January 2021 Annual report 2020: 26 January 2021 Annual General Meeting...
13 January, 2021 FluoGuide gets green light to proceed to third dose level with FG001 in the ongoing clinical phase I/II trial in patients with high grade glioma News Corporate Information Other Corporate Information English Regulatory MAR IR
Evaluation of the results from the second dose level of FG001, including data from three patients, has been finalized and reported...

2020

29 December, 2020 Board member of FluoGuide sells some of his shares to pay capital gain tax on his shareholding News Corporate Information Other Corporate Information English IR
“Due to Danish corporate tax regulations and the success of FluoGuide during 2020, I have to pay capital gain tax in my holding...

FluoGuideCalendar & events